Vaccine Production
The vaccines that are used to prevent some of the world’s deadliest diseases go through extensive testing and trials in order to ensure the safety of the general public. The stages of vaccine production, according to historyofvaccines.com are the exploratory stage, the preclinical stage, and then the three stages of clinical development.
The Stages of Development
Exploratory Stage
In the exploratory stage, a 2-4 year study takes place in identifying specific antigens and how they cause disease as well as how they would bee useful in vaccine production.
Pre-clinical Stage
In the preclinical stage, cell and animal testing is used to study the effectiveness of thee vaccine in question. They determine a safe starting dose as well as how the vaccine could be improved upon in the future. Challenge studies are also used, as animals are vaccinated and then infected with the pathogen to see the response and effectiveness of the vaccine.
Clinical Stage
There are three phase of the clinical stage of vaccine development. This is to ensure the safety of the recipients as well as how effective the vaccines is in preventing disease. Phase one includes a small number of adults that are given the vaccine, usually non-blinded, and thee researchers will assess the response of the immune system to the vaccine. Sometimes there will be a challenge study involved to test the effectiveness against a pathogen. Phase two involves hundreds of people as well as a placebo drug. Dose, frequency of immunizations, as well as method of delivery is established in phase two. Phase three involves thousands of people in aa double blind test. Thee large group is to identify any side effects that may occur with the vaccine as well as to study the immune response. After success with all three phases, a vaccine may get approved for use in the general public.
HIV Vaccine Development
Scientists and researchers have been trying for years to create a vaccine against the HIV virus that causes AIDS. So far, the virus has been extremely well equipped in blocking any vaccine attempt, but researchers at the Fred Hutchinson Cancer Research Center in Seattle have developed a way that may avoid the many factors that make HIV impossible to prevent. It involves a five step process in order for our B cells to more efficiently produce antibodies against the virus. There would be a precursor injection that would prompt the B cells to make the specific antibodies followed by four to five more injections that allow the body to recognize the different aspects of HIV that make it so virulent.